نتائج البحث - "Sodium/glucose cotransporter"

1

Sodium–glucose cotransporter 2 inhibitors in type 2 diabetes patients with renal function impairment slow the annual renal function decline, in a real clinical practice

المؤلفون: Keiji Shimada, Munehiro Kitada, Taro Hirai, Yoshio Ogura, Masaru Sakurai, Mizue Fujii, Yuta Takagaki, Kazunori Konishi, Atsushi Nakagawa, Daisuke Koya, Itaru Monno, Yoshihiro Hayashi, Erina Oda

المصدر: Journal of Diabetes Investigation, Vol 12, Iss 9, Pp 1577-1585 (2021)
Journal of Diabetes Investigation

مصطلحات موضوعية: Blood Glucose, Male, Sodium–glucose cotransporter 2 inhibitor, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Urology, Renal function, Type 2 diabetes, 030204 cardiovascular system & hematology, Egfr decline, Kidney, Annual change, Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, 0302 clinical medicine, Diabetes mellitus, Internal Medicine, Medicine, Humans, Diabetic Nephropathies, 030212 general & internal medicine, Practice Patterns, Physicians', Diabetic kidney disease, Sodium-Glucose Transporter 2 Inhibitors, Aged, Retrospective Studies, business.industry, General Medicine, Articles, medicine.disease, Prognosis, RC648-665, Clinical Practice, Clinical Science and Care, Diabetes Mellitus, Type 2, Sodium/Glucose Cotransporter 2, Albuminuria, Original Article, Female, medicine.symptom, business, Annual estimated glomerular filtration rate decline, Biomarkers, Follow-Up Studies, Glomerular Filtration Rate

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da5d0d77fff98537c2f3b5a129ad1353Test
https://doaj.org/article/b15014c99b144c01b71d312f5adb526fTest

2

Cardiovascular and renal outcomes with canagliflozin according to baseline diuretic use

المؤلفون: Abigail S. Baldridge, Clare Arnott, Mark D. Huffman, Hiddo J. L. Heersprink, Sanjiv J. Shah, Jie Yu, Yuli Huang, Gemma A. Figtree, Meg Jardine, Brendon L. Neuen, Christopher P. Cannon, Bruce Neal, Kenneth W. Mahaffey, Vlado Perkovic, Sadiya S. Khan, Chao Li

المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Groningen Kidney Center (GKC)

المصدر: ESC Heart Failure, Vol 8, Iss 2, Pp 1482-1493 (2021)
ESC Heart Failure
ESC Heart Failure, 8(2), 1482-1493. WILEY PERIODICALS, INC

مصطلحات موضوعية: medicine.medical_specialty, lcsh:Diseases of the circulatory (Cardiovascular) system, Cardiac & Cardiovascular Systems, Sodium‐glucose cotransporter 2 inhibitor (SGLT2i), medicine.medical_treatment, Subgroup analysis, 030204 cardiovascular system & hematology, Cardiovascular System, 03 medical and health sciences, 0302 clinical medicine, Original Research Articles, Internal medicine, Post-hoc analysis, medicine, Humans, Original Research Article, 030212 general & internal medicine, Risk factor, Canagliflozin, Adverse effect, Diuretics, Sodium-Glucose Transporter 2 Inhibitors, 1102 Cardiorespiratory Medicine and Haematology, Science & Technology, Proportional hazards model, business.industry, Corrigenda, Diabetes Mellitus, Type 2, lcsh:RC666-701, Cardiovascular System & Cardiology, Sodium-glucose cotransporter 2 inhibitor (SGLT2i), Female, Diuretic, Corrigendum, Cardiology and Cardiovascular Medicine, business, CANVAS Program, Life Sciences & Biomedicine, Mace, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db00bf68b929d76aabb45a118aa0aa02Test
https://doi.org/10.1002/ehf2.13236Test

3

Diabetes Management in Patients with Heart Failure

المؤلفون: Jia Shen, Barry H. Greenberg

المصدر: Diabetes & metabolism journal, vol 45, iss 2
Diabetes & Metabolism Journal, Vol 45, Iss 2, Pp 158-172 (2021)
Diabetes & Metabolism Journal

مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Prevalence, heart failure, 030209 endocrinology & metabolism, Review, Disease, 030204 cardiovascular system & hematology, Cardiovascular, lcsh:Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, Diabetes mellitus, 0302 clinical medicine, Clinical Research, Diabetes management, medicine, risk factors, Humans, In patient, Risk factor, Sodium glucose cotransporter 2 inhibitor, Intensive care medicine, Sodium-Glucose Transporter 2 Inhibitors, Metabolic and endocrine, Nutrition, Heart Failure, lcsh:RC648-665, business.industry, Cardiovascular Risk/Epidemiology, Prevention, Diabetes, Type 2 Diabetes Mellitus, medicine.disease, Heart Disease, Diabetes Mellitus, Type 2, Risk factors, 5.1 Pharmaceuticals, Heart failure, diabetes mellitus, business, sodium glucose cotransporter 2 inhibitor, Type 2

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b7a02002e5a7bd88cdc2fa6ba6dc1f8Test
https://doi.org/10.4093/dmj.2020.0296Test

4

Blood glucose levels and bodyweight change after dapagliflozin administration

المؤلفون: Hun-Sung Kim, Jae Hyoung Cho, Kun-Ho Yoon, Hyeon Woo Yim, Seung-Hwan Lee, Hyunyong Lee, Hyunah Kim

المصدر: Journal of Diabetes Investigation, Vol 12, Iss 9, Pp 1594-1602 (2021)
Journal of Diabetes Investigation

مصطلحات موضوعية: Adult, Blood Glucose, Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Sodium–glucose cotransporter 2, Diseases of the endocrine glands. Clinical endocrinology, Young Adult, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Weight loss, Diabetes mellitus, Internal medicine, Internal Medicine, medicine, Humans, In patient, 030212 general & internal medicine, Dapagliflozin, Sodium-Glucose Transporter 2 Inhibitors, Aged, Retrospective Studies, Glycated Hemoglobin, business.industry, Body Weight, Articles, General Medicine, Odds ratio, Middle Aged, Prognosis, Weight, RC648-665, medicine.disease, Clinical Science and Care, Endocrinology, Diabetes Mellitus, Type 2, chemistry, Hemoglobin A1c, Sodium/Glucose Cotransporter 2, Original Article, Female, Hemoglobin, medicine.symptom, business, Weight gain, Biomarkers, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcadbf2ce1670e7862357e3b25ececf3Test
https://doi.org/10.1111/jdi.13516Test

5

Sodium–glucose cotransporter 2 inhibitors reduce day‐to‐day glucose variability in patients with type 1 diabetes

المؤلفون: Hiroshi Nomoto, Kumiko Yamashita, Koki Chiba, Aika Miya, Shin Aoki, Hiraku Kameda, Hideaki Miyoshi, Yui Shibayama, Kyu Yong Cho, Tatsuya Atsumi, Akinobu Nakamura, Yoshio Kurihara

المصدر: Journal of Diabetes Investigation, Vol 12, Iss 2, Pp 176-183 (2021)
Journal of Diabetes Investigation

مصطلحات موضوعية: Blood Glucose, Male, Sodium–glucose cotransporter 2 inhibitor, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Hypoglycemia, Gastroenterology, Sodium-glucose cotransporter 2 inhibitor, Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Diabetes mellitus, Internal Medicine, medicine, Humans, Type 1 diabetes, 030212 general & internal medicine, Sodium-Glucose Transporter 2 Inhibitors, Retrospective Studies, Glycated Hemoglobin, business.industry, SGLT2 inhibitor, General Medicine, Articles, Glucose variability, Middle Aged, medicine.disease, Prognosis, RC648-665, Ketoacidosis, Diabetes Mellitus, Type 1, Clinical Science and Care, chemistry, Sodium/Glucose Cotransporter 2, Ketone bodies, Female, Original Article, Glycated hemoglobin, SGLT2 Inhibitor, business, Biomarkers, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e0a6dd795dd89d84d351957eb2433feTest
https://doaj.org/article/1dbe280944994136a7b013586e954b51Test

6

On‐label use of sodium–glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetes

المؤلفون: Akira Shimada, Koichiro Atsuda, Yoichi Oikawa, Takeshi Horii

المصدر: Journal of Diabetes Investigation, Vol 12, Iss 9, Pp 1586-1593 (2021)
Journal of Diabetes Investigation

مصطلحات موضوعية: Adult, Blood Glucose, Male, Sodium–glucose cotransporter 2 inhibitor, medicine.medical_specialty, Diabetic ketoacidosis, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, 0302 clinical medicine, Japan, Internal medicine, Diabetes mellitus, Internal Medicine, medicine, Humans, Type 1 diabetes, 030212 general & internal medicine, Sodium-Glucose Transporter 2 Inhibitors, Aged, Retrospective Studies, business.industry, Incidence (epidemiology), Incidence, Hazard ratio, General Medicine, Articles, Middle Aged, medicine.disease, Prognosis, RC648-665, Confidence interval, Diabetes Mellitus, Type 1, Clinical Science and Care, Female, Original Article, business, Body mass index, Biomarkers, Cohort study, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274d7c5c3890b639e90830aea459600aTest
https://doaj.org/article/52f48c8ed5824dd092e6adafd3588fbaTest

7

Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study

المصدر: Journal of Diabetes Investigation, Vol 12, Iss 8, Pp 1417-1424 (2021)
Journal of Diabetes Investigation

مصطلحات موضوعية: Blood Glucose, Male, Endocrinology, Diabetes and Metabolism, 030204 cardiovascular system & hematology, Gastroenterology, chemistry.chemical_compound, 0302 clinical medicine, Prospective Studies, Canagliflozin, Area under the curve, SGLT2 inhibitor, General Medicine, Articles, Postprandial, Clinical Science and Care, Post-Prandial Blood Glucose, Thiazolidines, Original Article, Drug Therapy, Combination, Female, medicine.drug, Adult, medicine.medical_specialty, Combination therapy, 030209 endocrinology & metabolism, Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, Diabetes mellitus, Internal medicine, Internal Medicine, medicine, DPP-4 inhibitor, Humans, Hypoglycemic Agents, Sodium–glucose cotransporter 2inhibitor, Teneligliptin, Sodium-Glucose Transporter 2 Inhibitors, Glycemic, Dipeptidyl-Peptidase IV Inhibitors, business.industry, Glucose Tolerance Test, medicine.disease, RC648-665, Post‐prandial blood glucose, chemistry, Diabetes Mellitus, Type 2, Hyperglycemia, Time in range, Pyrazoles, Glycated hemoglobin, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3760bc209d5ab90fd2836c21d04ec3e0Test
https://doaj.org/article/3e8bdc46ba6e43f5ae3287bfe8db2f38Test

8

Sodium–glucose cotransporter 2 inhibitor‐induced reduction in the mean arterial pressure improved renal composite outcomes in type 2 diabetes mellitus patients with chronic kidney disease: A propensity score‐matched model analysis in Japan

المؤلفون: Kazuyoshi Sato, Masaaki Miyakawa, Kouichi Tamura, Takayuki Furuki, Kazuo Kobayashi, Akira Kanamori, Masao Toyoda, Nobuo Hatori, Hiroyuki Sakai

المصدر: Journal of Diabetes Investigation, Vol 12, Iss 8, Pp 1408-1416 (2021)
Journal of Diabetes Investigation

مصطلحات موضوعية: Male, Mean arterial pressure, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Urology, Renal function, 030204 cardiovascular system & hematology, Kidney Function Tests, Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, 0302 clinical medicine, Japan, Diabetes mellitus, Chronic kidney disease, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Arterial Pressure, Diabetic Nephropathies, 030212 general & internal medicine, Renal Insufficiency, Chronic, Propensity Score, Sodium-Glucose Transporter 2 Inhibitors, Aged, Retrospective Studies, Models, Statistical, Sodium–glucose cotransporter 2 inhibitors, business.industry, Type 2 Diabetes Mellitus, General Medicine, Articles, Middle Aged, medicine.disease, RC648-665, Blood pressure, Treatment Outcome, Clinical Science and Care, Diabetes Mellitus, Type 2, Propensity score matching, Albuminuria, Female, Original Article, medicine.symptom, business, Kidney disease, Glomerular Filtration Rate

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::292c7952d7fd112071ee693b0fc5c9abTest
https://doaj.org/article/336ae2edd3f9447380440ee6088616c4Test

9

The role of sodium-glucose cotransporter 2 inhibitors in the treatment of type 2 diabetes: from clinical research to real practice

المؤلفون: V. A. Gubkina, Yu. A. Kovaleva, Inna Vladimirovna Misnikova

المصدر: Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 7, Pp 500-509 (2020)

مصطلحات موضوعية: endocrine system diseases, business.industry, 030209 endocrinology & metabolism, General Medicine, Type 2 diabetes, 030204 cardiovascular system & hematology, Pharmacology, medicine.disease, sodium-glucose cotransporter type 2 inhibitors, 03 medical and health sciences, 0302 clinical medicine, Clinical research, Sodium/Glucose Cotransporter 2, diabetes mellitus, glycemic control, Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1341cc82e095b607e3ed987765f55cbTest
https://doi.org/10.18786/2072-0505-2020-48-056Test

10

Ertugliflozin in the treatment of type 2 diabetes mellitus

المؤلفون: Joel C. Marrs, Sarah L. Anderson

المصدر: Drugs in Context, Vol 9, Pp 1-10 (2020)
Drugs in Context

مصطلحات موضوعية: medicine.medical_specialty, endocrine system diseases, ertugliflozin, sodium–glucose cotransporter 2 inhibitors, 030209 endocrinology & metabolism, Review, sodium-glucose cotransporter 2 inhibitors, Type 2 diabetes, 030204 cardiovascular system & hematology, body weight, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Diabetes mellitus, Empagliflozin, medicine, Glycemic, Pharmacology, Canagliflozin, business.industry, lcsh:RM1-950, blood pressure, nutritional and metabolic diseases, Type 2 Diabetes Mellitus, drug interactions, General Medicine, medicine.disease, Metformin, lcsh:Therapeutics. Pharmacology, Sitagliptin, diabetes mellitus, metabolic effects, adverse effects, Molecular Medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40c9a8afdcd8f6f97e1a358fe62c7159Test
https://doi.org/10.7573/dic.2020-7-4Test

تنقيح النتائج